Topical application of nonsteroidal anti-inflammatory drugs prevents vehicle-induced improvement of psoriasis
- 31 January 1986
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 14 (1) , 39-43
- https://doi.org/10.1016/s0190-9622(86)70004-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytesBritish Journal of Dermatology, 1985
- Biosynthesis of Lipoxygenase Products by Enzyme Preparations from Normal and Psoriatic SkinJournal of Investigative Dermatology, 1984
- Identification of Chemotactic Lipoxygenase Products of Arachidonate Metabolism in Psoriatic SkinJournal of Investigative Dermatology, 1984
- Production of Intraepidermal Microabscesses by Topical Application of Leukotriene B4Journal of Investigative Dermatology, 1984
- Leukotrienes: Clinical significanceJournal of the American Academy of Dermatology, 1984
- Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4British Journal of Pharmacology, 1983
- Arachidonic acid and prostanoids in suction blister fluid from psoriatic lesions and unaffected skinArchives of Dermatological Research, 1983
- Leukotrienes and Other Lipoxygenase Products in the Pathogenesis and Therapy of Psoriasis and Other DermatosesArchives of Dermatology, 1983
- PSORIASIS AND LEUKOTRIENE B4The Lancet, 1982
- Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.Proceedings of the National Academy of Sciences, 1975